Charming Medical Limited Class A Ordinary Shares

NASDAQ:MCTA

Medical - Care Facilities

Healthcare
$29.36 +0.00%

+$0.00 today

Market cap
$445.55M
Beta
0.00
P/E (TTM)
414.6
EPS (TTM)
$0.07
52W Low $4.30High $31.70

Volume 0.00M

Average 0.87M

MCTA Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA

Operating Margin · FY2024 · year ended Mar 2025

Operating margin widens to 22.3%

Operating margin was 22.3% in FY2024, up 5.6 pp from a year earlier.

Context

  • Operating margin widened in 2 of the last 2 fiscal years.
  • FY2024 was the highest level in the 3 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Last fiscal yearMar 2025
22.3%+5.6 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year+5.6 pp——
3 years———
5 years——
10 years——

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2024
22.3%
Year-over-year change
+5.6pp

Operating Margin vs competitors

How MCTA compares with its peers on the latest reported figures

  • MCTA's FY2024 operating margin of 22.3% is the highest of the 9 companies compared; the peer median is -6.4%.
  • Its year-over-year change of +5.6 pp is the 2nd highest of 9, against a peer median of -1.0 pp.
MCTA Competitors Peer median
Operating Margin for MCTA and competitors
Company Period LTM level YoY 3-year change
MCTACharming Medical Limited Class A Ordinary SharesFY202422.3% +5.6 pp—
TCMDTactile Systems Technology, Inc.LTM Mar 20269.4% +2.4 pp+14.1 pp
DCTHDelcath Systems, Inc.LTM Mar 2026-1.8% +1.0 pp+1245.8 pp
CCRNCross Country Healthcare, Inc.LTM Mar 2026-2.1% -0.4 pp-10.0 pp
TOIThe Oncology Institute, Inc.LTM Mar 2026-6.0% +6.9 pp+25.3 pp
AGLAgilon Health, Inc.LTM Mar 2026-6.8% -1.6 pp-2.7 pp
RXSTRxSight, Inc.LTM Mar 2026-43.4% -20.1 pp+93.4 pp
SLPSimulations Plus, Inc.LTM Feb 2026-83.5% -88.0 pp-117.0 pp
NAKANakamoto Inc.LTM Mar 2026-8221.8% -8053.8 pp-10752.9 pp
ANNXAnnexon, Inc.FY2025— ——
Peer median (excluding MCTA) -6.4%-1.0 pp+5.7 pp

Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
Revenue3.53M6.02M6.22M
Cost of Revenue2.04M2.1M2.04M
Gross Profit1.49M3.91M4.18M
Gross Margin42.3%65.1%67.2%
Research & Development000
Selling, General & Admin1.66M2.35M2.32M
Operating Expenses2.02M2.91M2.79M
Depreciation & Amortization211.08K391.7K263.45K
EBITDA(189.13K)1.42M1.72M
EBITDA Margin-5.4%23.6%27.6%
Operating Income(521.34K)1.01M1.39M
Operating Margin-14.8%16.8%22.3%
Interest Income10.29K19.51K64.14K
Interest Expense20.26K26.05K20.87K
Other Income / Expenses100.87K(5.35K)46.23K
Income Before Tax(420.47K)1M1.44M
Pre-Tax Margin-11.9%16.7%23.1%
Income Tax Expense(84.86K)181.75K236.08K
Net Income(305.12K)777.81K1.2M
Net Margin-8.6%12.9%19.3%
EPS (Basic)(0.02)0.050.07
EPS (Diluted)(0.02)0.050.07
Weighted Avg Shares16.94M16.94M16.94M
Weighted Avg Shares (Diluted)16.94M16.94M16.94M

Charming Medical Limited Class A Ordinary Shares

NASDAQ:MCTA

Intrinsic Alpha fair value

Locked

Current Price

$29.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.